
Gas chromatography–mass spectrometry (GC–MS) and ion chromatography profile wasabi and mustard heat and acidity.
The regulatory environment is changing and is starting to sweep away some of the commandments on which we have relied, and to change others almost unrecognizably. To make the transition, FDA will have to reinvent itself and industry will have to rethink the way we develop and manage our processes.
over 20 years ago
Analytical Instrument Qualificationover 20 years ago
GMP and Phase I Clinical Trials: Streamlining the Critical Path?over 20 years ago
Team Effortover 20 years ago
Rated PG: Pharmaceutical Guidance Suggestedover 20 years ago
European Clinical Trial Regulations Undergo a Slow Revolutionover 20 years ago
Moving Biotech Products from CBER to CDER: A Work in Progressover 20 years ago
New Climateover 20 years ago
CDER?s Division of Post-Marketing Evaluation for Quality Assessment




